What is PACELINE?
For over three decades, PACELINE has functioned as a critical pillar in the medical technology ecosystem, providing high-quality, custom-engineered solutions for orthopedic, prosthetic, and surgical applications. The company serves as a primary resource for medical product distributors and healthcare manufacturers, maintaining a reputation for precision and reliability. By bridging the gap between raw material innovation and clinical application, PACELINE occupies a vital niche in the healthcare supply chain, ensuring that practitioners have access to the specialized components necessary for complex medical interventions.
How much funding has PACELINE raised?
PACELINE has raised a total of $848K across 2 funding rounds:
Debt
$350K
Debt
$498K
Debt (2020): $350K with participation from PPP
Debt (2021): $498K led by PPP
Key Investors in PACELINE
PPP
Public-Private Partnership
What's next for PACELINE?
With the recent infusion of capital, PACELINE is expected to accelerate its strategic initiatives, focusing on scaling production capacity and enhancing its proprietary manufacturing processes. As the medical device industry faces increasing demand for custom orthotic and prosthetic solutions, the company is well-positioned to capitalize on market shifts toward personalized healthcare. Future growth will likely involve deepening its integration with existing distribution networks and exploring advanced material sciences to maintain its competitive edge in the global medical manufacturing landscape.
See full PACELINE company page
